학술논문

Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 10 January 2023, 41(2):212-221)
Subject
Language
English
ISSN
15277755
0732183X